<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1988-08-01" modified="2020-10-07" version="241">
<accession>P08253</accession>
<accession>B2R6U1</accession>
<accession>B4DWH3</accession>
<accession>E9PE45</accession>
<accession>Q9UCJ8</accession>
<name>MMP2_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="41 42">72 kDa type IV collagenase</fullName>
<ecNumber evidence="45 46 47 48">3.4.24.24</ecNumber>
</recommendedName>
<alternativeName>
<fullName evidence="40">72 kDa gelatinase</fullName>
</alternativeName>
<alternativeName>
<fullName>Gelatinase A</fullName>
</alternativeName>
<alternativeName>
<fullName>Matrix metalloproteinase-2</fullName>
<shortName>MMP-2</shortName>
</alternativeName>
<alternativeName>
<fullName>TBE-1</fullName>
</alternativeName>
<component>
<recommendedName>
<fullName>PEX</fullName>
</recommendedName>
</component>
</protein>
<gene>
<name type="primary">MMP2</name>
<name type="synonym">CLG4A</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1990" name="J. Biol. Chem." volume="265" first="11077" last="11082">
<title>Structure of the human type IV collagenase gene.</title>
<authorList>
<person name="Huhtala P."/>
<person name="Chow L.T."/>
<person name="Tryggvason K."/>
</authorList>
<dbReference type="PubMed" id="2162831"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1991" name="Genomics" volume="9" first="429" last="434">
<title>On the structure and chromosome location of the 72- and 92-kDa human type IV collagenase genes.</title>
<authorList>
<person name="Collier I.E."/>
<person name="Bruns G.A.P."/>
<person name="Goldberg G.I."/>
<person name="Gerhard D.S."/>
</authorList>
<dbReference type="PubMed" id="1851724"/>
<dbReference type="DOI" id="10.1016/0888-7543(91)90408-7"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3)</scope>
<source>
<tissue>Teratocarcinoma</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="2004-08" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS VAL-447 AND LEU-621</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nature" volume="432" first="988" last="994">
<title>The sequence and analysis of duplication-rich human chromosome 16.</title>
<authorList>
<person name="Martin J."/>
<person name="Han C."/>
<person name="Gordon L.A."/>
<person name="Terry A."/>
<person name="Prabhakar S."/>
<person name="She X."/>
<person name="Xie G."/>
<person name="Hellsten U."/>
<person name="Chan Y.M."/>
<person name="Altherr M."/>
<person name="Couronne O."/>
<person name="Aerts A."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Blumer H."/>
<person name="Branscomb E."/>
<person name="Brown N.C."/>
<person name="Bruno W.J."/>
<person name="Buckingham J.M."/>
<person name="Callen D.F."/>
<person name="Campbell C.S."/>
<person name="Campbell M.L."/>
<person name="Campbell E.W."/>
<person name="Caoile C."/>
<person name="Challacombe J.F."/>
<person name="Chasteen L.A."/>
<person name="Chertkov O."/>
<person name="Chi H.C."/>
<person name="Christensen M."/>
<person name="Clark L.M."/>
<person name="Cohn J.D."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Dickson M."/>
<person name="Dimitrijevic-Bussod M."/>
<person name="Escobar J."/>
<person name="Fawcett J.J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Goodstein D."/>
<person name="Goodwin L.A."/>
<person name="Grady D.L."/>
<person name="Grigoriev I."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Hildebrand C.E."/>
<person name="Huang W."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Jewett P.B."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Krawczyk M.-C."/>
<person name="Leyba T."/>
<person name="Longmire J.L."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Lowry S."/>
<person name="Ludeman T."/>
<person name="Manohar C.F."/>
<person name="Mark G.A."/>
<person name="McMurray K.L."/>
<person name="Meincke L.J."/>
<person name="Morgan J."/>
<person name="Moyzis R.K."/>
<person name="Mundt M.O."/>
<person name="Munk A.C."/>
<person name="Nandkeshwar R.D."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Predki P."/>
<person name="Parson-Quintana B."/>
<person name="Ramirez L."/>
<person name="Rash S."/>
<person name="Retterer J."/>
<person name="Ricke D.O."/>
<person name="Robinson D.L."/>
<person name="Rodriguez A."/>
<person name="Salamov A."/>
<person name="Saunders E.H."/>
<person name="Scott D."/>
<person name="Shough T."/>
<person name="Stallings R.L."/>
<person name="Stalvey M."/>
<person name="Sutherland R.D."/>
<person name="Tapia R."/>
<person name="Tesmer J.G."/>
<person name="Thayer N."/>
<person name="Thompson L.S."/>
<person name="Tice H."/>
<person name="Torney D.C."/>
<person name="Tran-Gyamfi M."/>
<person name="Tsai M."/>
<person name="Ulanovsky L.E."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="White P.S."/>
<person name="Williams A.L."/>
<person name="Wills P.L."/>
<person name="Wu J.-R."/>
<person name="Wu K."/>
<person name="Yang J."/>
<person name="DeJong P."/>
<person name="Bruce D."/>
<person name="Doggett N.A."/>
<person name="Deaven L."/>
<person name="Schmutz J."/>
<person name="Grimwood J."/>
<person name="Richardson P."/>
<person name="Rokhsar D.S."/>
<person name="Eichler E.E."/>
<person name="Gilna P."/>
<person name="Lucas S.M."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
<person name="Pennacchio L.A."/>
</authorList>
<dbReference type="PubMed" id="15616553"/>
<dbReference type="DOI" id="10.1038/nature03187"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1990" name="Genomics" volume="6" first="554" last="559">
<title>Completion of the primary structure of the human type IV collagenase preproenzyme and assignment of the gene (CLG4) to the q21 region of chromosome 16.</title>
<authorList>
<person name="Huhtala P."/>
<person name="Eddy R.L."/>
<person name="Fan Y.S."/>
<person name="Byers M.G."/>
<person name="Shows T.B."/>
<person name="Tryggvason K."/>
</authorList>
<dbReference type="PubMed" id="2158484"/>
<dbReference type="DOI" id="10.1016/0888-7543(90)90486-e"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-51</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1988" name="J. Biol. Chem." volume="263" first="6579" last="6587">
<title>H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen.</title>
<authorList>
<person name="Collier I.E."/>
<person name="Wilhelm S.M."/>
<person name="Eisen A.Z."/>
<person name="Marmer B.L."/>
<person name="Grant G.A."/>
<person name="Seltzer J.L."/>
<person name="Kronberger A."/>
<person name="He C."/>
<person name="Bauer E.A."/>
<person name="Goldberg G.I."/>
</authorList>
<dbReference type="PubMed" id="2834383"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 19-660 (ISOFORM 1)</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1992" name="Matrix Suppl." volume="1" first="299" last="306">
<title>TIMP-2: identification and characterization of a new member of the metalloproteinase inhibitor family.</title>
<authorList>
<person name="Stetler-Stevenson W.G."/>
<person name="Krutzsch H.C."/>
<person name="Liotta L.A."/>
</authorList>
<dbReference type="PubMed" id="1480041"/>
</citation>
<scope>PROTEIN SEQUENCE OF 30-44</scope>
<source>
<tissue>Melanoma</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="1991" name="J. Biol. Chem." volume="266" first="17972" last="17977">
<title>Binding of tissue inhibitor of metalloproteinases 2 to two distinct sites on human 72-kDa gelatinase. Identification of a stabilization site.</title>
<authorList>
<person name="Howard E.W."/>
<person name="Banda M.J."/>
</authorList>
<dbReference type="PubMed" id="1655733"/>
</citation>
<scope>INTERACTION WITH TIMP2</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1996" name="Cell" volume="85" first="683" last="693">
<title>Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.</title>
<authorList>
<person name="Brooks P.C."/>
<person name="Stroemblad S."/>
<person name="Sanders L.C."/>
<person name="von Schalscha T.L."/>
<person name="Aimes R.T."/>
<person name="Stetler-Stevenson W.G."/>
<person name="Quigley J.P."/>
<person name="Cheresh D.A."/>
</authorList>
<dbReference type="PubMed" id="8646777"/>
<dbReference type="DOI" id="10.1016/s0092-8674(00)81235-0"/>
</citation>
<scope>IDENTIFICATION OF RECEPTOR</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1997" name="Eur. J. Biochem." volume="244" first="653" last="657">
<title>Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases.</title>
<authorList>
<person name="Butler G.S."/>
<person name="Will H."/>
<person name="Atkinson S.J."/>
<person name="Murphy G."/>
</authorList>
<dbReference type="PubMed" id="9119036"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1997.t01-1-00653.x"/>
</citation>
<scope>PROTEOLYTIC PROCESSING</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1998" name="Cell" volume="92" first="391" last="400">
<title>Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity.</title>
<authorList>
<person name="Brooks P.C."/>
<person name="Silletti S."/>
<person name="von Schalscha T.L."/>
<person name="Friedlander M."/>
<person name="Cheresh D.A."/>
</authorList>
<dbReference type="PubMed" id="9476898"/>
<dbReference type="DOI" id="10.1016/s0092-8674(00)80931-9"/>
</citation>
<scope>IDENTIFICATION OF RECEPTOR</scope>
<scope>FUNCTION OF PEX</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1999" name="Circ. Res." volume="85" first="906" last="911">
<title>Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor.</title>
<authorList>
<person name="Fernandez-Patron C."/>
<person name="Radomski M.W."/>
<person name="Davidge S.T."/>
</authorList>
<dbReference type="PubMed" id="10559137"/>
<dbReference type="DOI" id="10.1161/01.res.85.10.906"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2000" name="Circ. Res." volume="87" first="670" last="676">
<title>Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction.</title>
<authorList>
<person name="Fernandez-Patron C."/>
<person name="Stewart K.G."/>
<person name="Zhang Y."/>
<person name="Koivunen E."/>
<person name="Radomski M.W."/>
<person name="Davidge S.T."/>
</authorList>
<dbReference type="PubMed" id="11029402"/>
<dbReference type="DOI" id="10.1161/01.res.87.8.670"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2001" name="Cancer Res." volume="61" first="8730" last="8736">
<title>Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2.</title>
<authorList>
<person name="Bello L."/>
<person name="Lucini V."/>
<person name="Carrabba G."/>
<person name="Giussani C."/>
<person name="Machluf M."/>
<person name="Pluderi M."/>
<person name="Nikas D."/>
<person name="Zhang J."/>
<person name="Tomei G."/>
<person name="Villani R.M."/>
<person name="Carroll R.S."/>
<person name="Bikfalvi A."/>
<person name="Black P.M."/>
</authorList>
<dbReference type="PubMed" id="11751392"/>
</citation>
<scope>FUNCTION OF PEX</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INTERACTION WITH TIMP2</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2001" name="Infect. Immun." volume="69" first="1402" last="1408">
<title>Salivary histatin 5 is an inhibitor of both host and bacterial enzymes implicated in periodontal disease.</title>
<authorList>
<person name="Gusman H."/>
<person name="Travis J."/>
<person name="Helmerhorst E.J."/>
<person name="Potempa J."/>
<person name="Troxler R.F."/>
<person name="Oppenheim F.G."/>
</authorList>
<dbReference type="PubMed" id="11179305"/>
<dbReference type="DOI" id="10.1128/iai.69.3.1402-1408.2001"/>
</citation>
<scope>ACTIVITY REGULATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2001" name="J. Cancer Res. Clin. Oncol." volume="127" first="653" last="658">
<title>Human cervical tumor cell (SiHa) surface alphavbeta3 integrin receptor has associated matrix metalloproteinase (MMP-2) activity.</title>
<authorList>
<person name="Chattopadhyay N."/>
<person name="Mitra A."/>
<person name="Frei E."/>
<person name="Chatterjee A."/>
</authorList>
<dbReference type="PubMed" id="11710594"/>
<dbReference type="DOI" id="10.1007/s004320100271"/>
</citation>
<scope>IDENTIFICATION OF RECEPTOR</scope>
<scope>INTERACTION WITH TMP2</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2003" name="Invest. Ophthalmol. Vis. Sci." volume="44" first="2163" last="2170">
<title>Production and activation of matrix metalloproteinase-2 in proliferative diabetic retinopathy.</title>
<authorList>
<person name="Noda K."/>
<person name="Ishida S."/>
<person name="Inoue M."/>
<person name="Obata K."/>
<person name="Oguchi Y."/>
<person name="Okada Y."/>
<person name="Ikeda E."/>
</authorList>
<dbReference type="PubMed" id="12714657"/>
<dbReference type="DOI" id="10.1167/iovs.02-0662"/>
</citation>
<scope>FUNCTION IN THE FORMATION OF THE FIBROVASCULAR TISSUES</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2003" name="Oncogene" volume="22" first="4617" last="4626">
<title>Cleavage of metastasis suppressor gene product KiSS-1 protein/metastin by matrix metalloproteinases.</title>
<authorList>
<person name="Takino T."/>
<person name="Koshikawa N."/>
<person name="Miyamori H."/>
<person name="Tanaka M."/>
<person name="Sasaki T."/>
<person name="Okada Y."/>
<person name="Seiki M."/>
<person name="Sato H."/>
</authorList>
<dbReference type="PubMed" id="12879005"/>
<dbReference type="DOI" id="10.1038/sj.onc.1206542"/>
</citation>
<scope>PROTEOLYTIC PROCESSING OF KISS1</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2004" name="FASEB J." volume="18" first="690" last="692">
<title>Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP-ribose) polymerase (PARP) in vitro.</title>
<authorList>
<person name="Kwan J.A."/>
<person name="Schulze C.J."/>
<person name="Wang W."/>
<person name="Leon H."/>
<person name="Sariahmetoglu M."/>
<person name="Sung M."/>
<person name="Sawicka J."/>
<person name="Sims D.E."/>
<person name="Sawicki G."/>
<person name="Schulz R."/>
</authorList>
<dbReference type="PubMed" id="14766804"/>
<dbReference type="DOI" id="10.1096/fj.02-1202fje"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2007" name="FASEB J." volume="21" first="2486" last="2495">
<title>Regulation of matrix metalloproteinase-2 (MMP-2) activity by phosphorylation.</title>
<authorList>
<person name="Sariahmetoglu M."/>
<person name="Crawford B.D."/>
<person name="Leon H."/>
<person name="Sawicka J."/>
<person name="Li L."/>
<person name="Ballermann B.J."/>
<person name="Holmes C."/>
<person name="Berthiaume L.G."/>
<person name="Holt A."/>
<person name="Sawicki G."/>
<person name="Schulz R."/>
</authorList>
<dbReference type="PubMed" id="17435175"/>
<dbReference type="DOI" id="10.1096/fj.06-7938com"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Cardiovasc. Res." volume="83" first="698" last="706">
<title>Glycogen synthase kinase-3beta is activated by matrix metalloproteinase-2 mediated proteolysis in cardiomyoblasts.</title>
<authorList>
<person name="Kandasamy A.D."/>
<person name="Schulz R."/>
</authorList>
<dbReference type="PubMed" id="19493954"/>
<dbReference type="DOI" id="10.1093/cvr/cvp175"/>
</citation>
<scope>INTERACTION WITH GSK3B</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="Pharmacology" volume="83" first="18" last="25">
<title>Aspirin inhibits MMP-2 and MMP-9 expressions and activities through upregulation of PPARalpha/gamma and TIMP gene expressions in ox-LDL-stimulated macrophages derived from human monocytes.</title>
<authorList>
<person name="Hua Y."/>
<person name="Xue J."/>
<person name="Sun F."/>
<person name="Zhu L."/>
<person name="Xie M."/>
</authorList>
<dbReference type="PubMed" id="18971601"/>
<dbReference type="DOI" id="10.1159/000166183"/>
</citation>
<scope>INDUCTION</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2012" name="J. Proteome Res." volume="11" first="4733" last="4743">
<title>Resveratrol-induced changes of the human adipocyte secretion profile.</title>
<authorList>
<person name="Rosenow A."/>
<person name="Noben J.P."/>
<person name="Jocken J."/>
<person name="Kallendrusch S."/>
<person name="Fischer-Posovszky P."/>
<person name="Mariman E.C."/>
<person name="Renes J."/>
</authorList>
<dbReference type="PubMed" id="22905912"/>
<dbReference type="DOI" id="10.1021/pr300539b"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E34177" last="E34177">
<title>A novel intracellular isoform of matrix metalloproteinase-2 induced by oxidative stress activates innate immunity.</title>
<authorList>
<person name="Lovett D.H."/>
<person name="Mahimkar R."/>
<person name="Raffai R.L."/>
<person name="Cape L."/>
<person name="Maklashina E."/>
<person name="Cecchini G."/>
<person name="Karliner J.S."/>
</authorList>
<dbReference type="PubMed" id="22509276"/>
<dbReference type="DOI" id="10.1371/journal.pone.0034177"/>
</citation>
<scope>ALTERNATIVE SPLICING (ISOFORM 2)</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="27" evidence="4">
<citation type="journal article" date="1995" name="Nat. Struct. Biol." volume="2" first="938" last="942">
<title>Crystal structure of the haemopexin-like C-terminal domain of gelatinase A.</title>
<authorList>
<person name="Libson A.M."/>
<person name="Gittis A.G."/>
<person name="Collier I.E."/>
<person name="Marmer B.L."/>
<person name="Goldberg G.I."/>
<person name="Lattman E.E."/>
</authorList>
<dbReference type="PubMed" id="7583664"/>
<dbReference type="DOI" id="10.1038/nsb1195-938"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 443-660</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="28" evidence="10">
<citation type="journal article" date="1996" name="FEBS Lett." volume="378" first="126" last="130">
<title>The C-terminal (haemopexin-like) domain structure of human gelatinase A (MMP2): structural implications for its function.</title>
<authorList>
<person name="Gohlke U."/>
<person name="Gomis-Rueth F.-X."/>
<person name="Crabbe T."/>
<person name="Murphy G."/>
<person name="Docherty A.J."/>
<person name="Bode W."/>
</authorList>
<dbReference type="PubMed" id="8549817"/>
<dbReference type="DOI" id="10.1016/0014-5793(95)01435-7"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 451-660 IN COMPLEX WITH CALCIUM</scope>
<scope>COFACTOR</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="29" evidence="1">
<citation type="journal article" date="1999" name="Science" volume="284" first="1667" last="1670">
<title>Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed.</title>
<authorList>
<person name="Morgunova E."/>
<person name="Tuuttila A."/>
<person name="Bergmann U."/>
<person name="Isupov M."/>
<person name="Lindqvist Y."/>
<person name="Schneider G."/>
<person name="Tryggvason K."/>
</authorList>
<dbReference type="PubMed" id="10356396"/>
<dbReference type="DOI" id="10.1126/science.284.5420.1667"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 30-660 OF MUTANT ALA-404 IN COMPLEX WITH CALCIUM AND ZINC IONS</scope>
<scope>ACTIVE SITE</scope>
<scope>COFACTOR</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="30" evidence="2">
<citation type="journal article" date="1999" name="Structure" volume="7" first="1235" last="1245">
<title>The second type II module from human matrix metalloproteinase 2: structure, function and dynamics.</title>
<authorList>
<person name="Briknarova K."/>
<person name="Grishaev A."/>
<person name="Banyai L."/>
<person name="Tordai H."/>
<person name="Patthy L."/>
<person name="Llinas M."/>
</authorList>
<dbReference type="PubMed" id="10545322"/>
<dbReference type="DOI" id="10.1016/s0969-2126(00)80057-x"/>
</citation>
<scope>STRUCTURE BY NMR OF 278-336</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="31" evidence="7">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="27613" last="27621">
<title>Gelatin-binding region of human matrix metalloproteinase-2: solution structure, dynamics, and function of the COL-23 two-domain construct.</title>
<authorList>
<person name="Briknarova K."/>
<person name="Gehrmann M."/>
<person name="Banyai L."/>
<person name="Tordai H."/>
<person name="Patthy L."/>
<person name="Llinas M."/>
</authorList>
<dbReference type="PubMed" id="11320090"/>
<dbReference type="DOI" id="10.1074/jbc.m101105200"/>
</citation>
<scope>STRUCTURE BY NMR OF 337-394 OF WILD TYPE AND IN COMPLEX WITH PPG PEPTIDES</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="32" evidence="6">
<citation type="journal article" date="2002" name="Biochim. Biophys. Acta" volume="1598" first="10" last="23">
<title>Solution structure and backbone dynamics of the catalytic domain of matrix metalloproteinase-2 complexed with a hydroxamic acid inhibitor.</title>
<authorList>
<person name="Feng Y."/>
<person name="Likos J.J."/>
<person name="Zhu L."/>
<person name="Woodward H."/>
<person name="Munie G."/>
<person name="McDonald J.J."/>
<person name="Stevens A.M."/>
<person name="Howard C.P."/>
<person name="De Crescenzo G.A."/>
<person name="Welsch D."/>
<person name="Shieh H.S."/>
<person name="Stallings W.C."/>
</authorList>
<dbReference type="PubMed" id="12147339"/>
<dbReference type="DOI" id="10.1016/s0167-4838(02)00307-2"/>
</citation>
<scope>STRUCTURE BY NMR OF 110-446 IN COMPLEX WITH A HYDROXAMIC ACID INHIBITOR</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>COFACTOR</scope>
</reference>
<reference key="33" evidence="8">
<citation type="journal article" date="2002" name="Biol. Chem." volume="383" first="137" last="148">
<title>The col-1 module of human matrix metalloproteinase-2 (MMP-2): structural/functional relatedness between gelatin-binding fibronectin type II modules and lysine-binding kringle domains.</title>
<authorList>
<person name="Gehrmann M."/>
<person name="Briknarova K."/>
<person name="Banyai L."/>
<person name="Patthy L."/>
<person name="Llinas M."/>
</authorList>
<dbReference type="PubMed" id="11928808"/>
<dbReference type="DOI" id="10.1515/bc.2002.014"/>
</citation>
<scope>STRUCTURE BY NMR OF 223-282 OF WILD TYPE AND IN COMPLEX WITH A PPG PEPTIDE</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="34" evidence="5">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="7414" last="7419">
<title>Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2.</title>
<authorList>
<person name="Morgunova E."/>
<person name="Tuuttila A."/>
<person name="Bergmann U."/>
<person name="Tryggvason K."/>
</authorList>
<dbReference type="PubMed" id="12032297"/>
<dbReference type="DOI" id="10.1073/pnas.102185399"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.1 ANGSTROMS) OF 30-660 IN COMPLEX WITH CALCIUM; ZINC IONS AND INHIBITOR TIMP2</scope>
<scope>COFACTOR</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="35" evidence="11">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="33236" last="33243">
<title>Structural basis for matrix metalloproteinase-2 (MMP-2)-selective inhibitory action of beta-amyloid precursor protein-derived inhibitor.</title>
<authorList>
<person name="Hashimoto H."/>
<person name="Takeuchi T."/>
<person name="Komatsu K."/>
<person name="Miyazaki K."/>
<person name="Sato M."/>
<person name="Higashi S."/>
</authorList>
<dbReference type="PubMed" id="21813640"/>
<dbReference type="DOI" id="10.1074/jbc.m111.264176"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 110-450 IN COMPLEX WITH PEPTIDE INHIBITOR; CALCIUM AND ZINC IONS</scope>
<scope>COFACTOR</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2001" name="Nat. Genet." volume="28" first="261" last="265">
<title>Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome.</title>
<authorList>
<person name="Martignetti J.A."/>
<person name="Aqeel A.A."/>
<person name="Sewairi W.A."/>
<person name="Boumah C.E."/>
<person name="Kambouris M."/>
<person name="Mayouf S.A."/>
<person name="Sheth K.V."/>
<person name="Eid W.A."/>
<person name="Dowling O."/>
<person name="Harris J."/>
<person name="Glucksman M.J."/>
<person name="Bahabri S."/>
<person name="Meyer B.F."/>
<person name="Desnick R.J."/>
</authorList>
<dbReference type="PubMed" id="11431697"/>
<dbReference type="DOI" id="10.1038/90100"/>
</citation>
<scope>VARIANT MONA HIS-101</scope>
<scope>VARIANT TYR-210</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2005" name="Clin. Genet." volume="67" first="261" last="266">
<title>Winchester syndrome caused by a homozygous mutation affecting the active site of matrix metalloproteinase 2.</title>
<authorList>
<person name="Zankl A."/>
<person name="Bonafe L."/>
<person name="Calcaterra V."/>
<person name="Di Rocco M."/>
<person name="Superti-Furga A."/>
</authorList>
<dbReference type="PubMed" id="15691365"/>
<dbReference type="DOI" id="10.1111/j.1399-0004.2004.00402.x"/>
</citation>
<scope>VARIANT MONA LYS-404</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2006" name="Clin. Genet." volume="69" first="271" last="276">
<title>A novel homozygous MMP2 mutation in a family with Winchester syndrome.</title>
<authorList>
<person name="Rouzier C."/>
<person name="Vanatka R."/>
<person name="Bannwarth S."/>
<person name="Philip N."/>
<person name="Coussement A."/>
<person name="Paquis-Flucklinger V."/>
<person name="Lambert J.-C."/>
</authorList>
<dbReference type="PubMed" id="16542393"/>
<dbReference type="DOI" id="10.1111/j.1399-0004.2006.00584.x"/>
</citation>
<scope>VARIANT MONA VAL-400 DEL</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] THR-228; MET-498 AND ILE-644</scope>
</reference>
<comment type="function">
<text>Ubiquitinous metalloproteinase that is involved in diverse functions such as remodeling of the vasculature, angiogenesis, tissue repair, tumor invasion, inflammation, and atherosclerotic plaque rupture. As well as degrading extracellular matrix proteins, can also act on several nonmatrix proteins such as big endothelial 1 and beta-type CGRP promoting vasoconstriction. Also cleaves KISS at a Gly-|-Leu bond. Appears to have a role in myocardial cell death pathways. Contributes to myocardial oxidative stress by regulating the activity of GSK3beta. Cleaves GSK3beta in vitro. Involved in the formation of the fibrovascular tissues in association with MMP14.</text>
</comment>
<comment type="function">
<text>PEX, the C-terminal non-catalytic fragment of MMP2, posseses anti-angiogenic and anti-tumor properties and inhibits cell migration and cell adhesion to FGF2 and vitronectin. Ligand for integrinv/beta3 on the surface of blood vessels.</text>
</comment>
<comment type="function">
<molecule>Isoform 2</molecule>
<text>Mediates the proteolysis of CHUK/IKKA and initiates a primary innate immune response by inducing mitochondrial-nuclear stress signaling with activation of the pro-inflammatory NF-kappaB, NFAT and IRF transcriptional pathways.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="45 46 47 48">
<text>Cleavage of gelatin type I and collagen types IV, V, VII, X. Cleaves the collagen-like sequence Pro-Gln-Gly-|-Ile-Ala-Gly-Gln.</text>
<dbReference type="EC" id="3.4.24.24"/>
</reaction>
</comment>
<comment type="cofactor">
<cofactor evidence="16 25 34 36">
<name>Ca(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29108"/>
</cofactor>
<text evidence="16 34 36">Binds 4 Ca(2+) ions per subunit.</text>
</comment>
<comment type="cofactor">
<cofactor evidence="16 24 25 34">
<name>Zn(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29105"/>
</cofactor>
<text evidence="16 24 34">Binds 2 Zn(2+) ions per subunit.</text>
</comment>
<comment type="activity regulation">
<text evidence="18">Inhibited by histatin-3 1/24 (histatin-5).</text>
</comment>
<comment type="subunit">
<text evidence="19 21 22 23 24 25 29 33">Interacts (via the C-terminal hemopexin-like domains-containing region) with the integrin alpha-V/beta-3; the interaction promotes vascular invasion in angiogenic vessels and melamoma cells. Interacts (via the C-terminal PEX domain) with TIMP2 (via the C-terminal); the interaction inhibits the degradation activity. Interacts with GSK3B.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1033518">
<id>P08253</id>
</interactant>
<interactant intactId="EBI-821758">
<id>PRO_0000000092</id>
<label>APP</label>
<dbReference type="UniProtKB" id="P05067"/>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1033518">
<id>P08253</id>
</interactant>
<interactant intactId="EBI-2431589">
<id>PRO_0000000093</id>
<label>APP</label>
<dbReference type="UniProtKB" id="P05067"/>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1033518">
<id>P08253</id>
</interactant>
<interactant intactId="EBI-2464511">
<id>P20908</id>
<label>COL5A1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1033518">
<id>P08253</id>
</interactant>
<interactant intactId="EBI-7539251">
<id>Q8NBP7</id>
<label>PCSK9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1033518">
<id>P08253</id>
</interactant>
<interactant intactId="EBI-10829018">
<id>Q04864-2</id>
<label>REL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1033518">
<id>P08253</id>
</interactant>
<interactant intactId="EBI-4479975">
<id>Q8IX30</id>
<label>SCUBE3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1033518">
<id>P08253</id>
</interactant>
<interactant intactId="EBI-1033507">
<id>P16035</id>
<label>TIMP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<molecule>Isoform 1</molecule>
<subcellularLocation>
<location evidence="48">Secreted</location>
<location evidence="48">Extracellular space</location>
<location evidence="48">Extracellular matrix</location>
</subcellularLocation>
<subcellularLocation>
<location>Membrane</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<text>Colocalizes with integrin alphaV/beta3 at the membrane surface in angiogenic blood vessels and melanomas. Found in mitochondria, along microfibrils, and in nuclei of cardiomyocytes.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Mitochondrion</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P08253-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P08253-2</id>
<name>2</name>
<sequence type="described" ref="VSP_044631"/>
</isoform>
<isoform>
<id>P08253-3</id>
<name>3</name>
<sequence type="described" ref="VSP_045704"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="22">Produced by normal skin fibroblasts. PEX is expressed in a number of tumors including gliomas, breast and prostate.</text>
</comment>
<comment type="induction">
<text evidence="32">Aspirin appears to inhibit expression.</text>
</comment>
<comment type="domain">
<text>The conserved cysteine present in the cysteine-switch motif binds the catalytic zinc ion, thus inhibiting the enzyme. The dissociation of the cysteine from the zinc ion upon the activation-peptide release activates the enzyme.</text>
</comment>
<comment type="PTM">
<text evidence="31">Phosphorylation on multiple sites modulates enzymatic activity. Phosphorylated by PKC in vitro.</text>
</comment>
<comment type="PTM">
<text evidence="26 37">The propeptide is processed by MMP14 (MT-MMP1) and MMP16 (MT-MMP3). Autocatalytic cleavage in the C-terminal produces the anti-angiogenic peptide, PEX. This processing appears to be facilitated by binding integrinv/beta3.</text>
</comment>
<comment type="disease" evidence="20 27 28">
<disease id="DI-02374">
<name>Multicentric osteolysis, nodulosis, and arthropathy</name>
<acronym>MONA</acronym>
<description>An autosomal recessive syndrome characterized by severe multicentric osteolysis with predominant involvement of the hands and feet. Additional features include coarse face, corneal opacities, patches of thickened, hyperpigmented skin, hypertrichosis and gum hypertrophy.</description>
<dbReference type="MIM" id="259600"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 2</molecule>
<text evidence="43">Induced by oxidative stress.</text>
</comment>
<comment type="similarity">
<text evidence="43">Belongs to the peptidase M10A family.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/MMP2ID41396ch16q13.html"/>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/mmp2/"/>
</comment>
<dbReference type="EC" id="3.4.24.24" evidence="45 46 47 48"/>
<dbReference type="EMBL" id="M55593">
<property type="protein sequence ID" value="AAA52028.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M58552">
<property type="protein sequence ID" value="AAA52028.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M55582">
<property type="protein sequence ID" value="AAA52028.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M55583">
<property type="protein sequence ID" value="AAA52028.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M55584">
<property type="protein sequence ID" value="AAA52028.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M55585">
<property type="protein sequence ID" value="AAA52028.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M55586">
<property type="protein sequence ID" value="AAA52028.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M55587">
<property type="protein sequence ID" value="AAA52028.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M55588">
<property type="protein sequence ID" value="AAA52028.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M55589">
<property type="protein sequence ID" value="AAA52028.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M55590">
<property type="protein sequence ID" value="AAA52028.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M55591">
<property type="protein sequence ID" value="AAA52028.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M55592">
<property type="protein sequence ID" value="AAA52028.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK301536">
<property type="protein sequence ID" value="BAG63035.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK310314">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK312711">
<property type="protein sequence ID" value="BAG35588.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY738117">
<property type="protein sequence ID" value="AAU10089.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC007336">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC092722">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC002576">
<property type="protein sequence ID" value="AAH02576.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M33789">
<property type="protein sequence ID" value="AAA52027.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="J03210">
<property type="protein sequence ID" value="AAA35701.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS10752.1">
<molecule id="P08253-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS45487.1">
<molecule id="P08253-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS76869.1">
<molecule id="P08253-2"/>
</dbReference>
<dbReference type="PIR" id="A28153">
<property type="entry name" value="A28153"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001121363.1">
<molecule id="P08253-3"/>
<property type="nucleotide sequence ID" value="NM_001127891.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001289437.1">
<molecule id="P08253-2"/>
<property type="nucleotide sequence ID" value="NM_001302508.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001289438.1">
<molecule id="P08253-2"/>
<property type="nucleotide sequence ID" value="NM_001302509.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001289439.1">
<molecule id="P08253-2"/>
<property type="nucleotide sequence ID" value="NM_001302510.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004521.1">
<molecule id="P08253-1"/>
<property type="nucleotide sequence ID" value="NM_004530.5"/>
</dbReference>
<dbReference type="PDB" id="1CK7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=30-660"/>
</dbReference>
<dbReference type="PDB" id="1CXW">
<property type="method" value="NMR"/>
<property type="chains" value="A=278-336"/>
</dbReference>
<dbReference type="PDB" id="1EAK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.66"/>
<property type="chains" value="A/B/C/D=32-452"/>
</dbReference>
<dbReference type="PDB" id="1GEN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="A=443-660"/>
</dbReference>
<dbReference type="PDB" id="1GXD">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A/B=30-660"/>
</dbReference>
<dbReference type="PDB" id="1HOV">
<property type="method" value="NMR"/>
<property type="chains" value="A=110-214, A=395-446"/>
</dbReference>
<dbReference type="PDB" id="1J7M">
<property type="method" value="NMR"/>
<property type="chains" value="A=337-394"/>
</dbReference>
<dbReference type="PDB" id="1KS0">
<property type="method" value="NMR"/>
<property type="chains" value="A=223-282"/>
</dbReference>
<dbReference type="PDB" id="1QIB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=115-213, A=394-449"/>
</dbReference>
<dbReference type="PDB" id="1RTG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=451-660"/>
</dbReference>
<dbReference type="PDB" id="3AYU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=110-450"/>
</dbReference>
<dbReference type="PDBsum" id="1CK7"/>
<dbReference type="PDBsum" id="1CXW"/>
<dbReference type="PDBsum" id="1EAK"/>
<dbReference type="PDBsum" id="1GEN"/>
<dbReference type="PDBsum" id="1GXD"/>
<dbReference type="PDBsum" id="1HOV"/>
<dbReference type="PDBsum" id="1J7M"/>
<dbReference type="PDBsum" id="1KS0"/>
<dbReference type="PDBsum" id="1QIB"/>
<dbReference type="PDBsum" id="1RTG"/>
<dbReference type="PDBsum" id="3AYU"/>
<dbReference type="SMR" id="P08253"/>
<dbReference type="BioGRID" id="110457">
<property type="interactions" value="43"/>
</dbReference>
<dbReference type="CORUM" id="P08253"/>
<dbReference type="IntAct" id="P08253">
<property type="interactions" value="40"/>
</dbReference>
<dbReference type="MINT" id="P08253"/>
<dbReference type="STRING" id="9606.ENSP00000219070"/>
<dbReference type="BindingDB" id="P08253"/>
<dbReference type="ChEMBL" id="CHEMBL333"/>
<dbReference type="DrugBank" id="DB05387">
<property type="generic name" value="AE-941"/>
</dbReference>
<dbReference type="DrugBank" id="DB01197">
<property type="generic name" value="Captopril"/>
</dbReference>
<dbReference type="DrugBank" id="DB06423">
<property type="generic name" value="Endostatin"/>
</dbReference>
<dbReference type="DrugBank" id="DB04866">
<property type="generic name" value="Halofuginone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00786">
<property type="generic name" value="Marimastat"/>
</dbReference>
<dbReference type="DrugBank" id="DB01630">
<property type="generic name" value="SC-74020"/>
</dbReference>
<dbReference type="DrugCentral" id="P08253"/>
<dbReference type="GuidetoPHARMACOLOGY" id="1629"/>
<dbReference type="MEROPS" id="M10.003"/>
<dbReference type="CarbonylDB" id="P08253"/>
<dbReference type="GlyGen" id="P08253">
<property type="glycosylation" value="3 sites, 2 O-linked glycans (1 site)"/>
</dbReference>
<dbReference type="iPTMnet" id="P08253"/>
<dbReference type="PhosphoSitePlus" id="P08253"/>
<dbReference type="BioMuta" id="MMP2"/>
<dbReference type="DMDM" id="116856"/>
<dbReference type="CPTAC" id="non-CPTAC-2615"/>
<dbReference type="EPD" id="P08253"/>
<dbReference type="jPOST" id="P08253"/>
<dbReference type="MassIVE" id="P08253"/>
<dbReference type="MaxQB" id="P08253"/>
<dbReference type="PaxDb" id="P08253"/>
<dbReference type="PeptideAtlas" id="P08253"/>
<dbReference type="PRIDE" id="P08253"/>
<dbReference type="ProteomicsDB" id="19808"/>
<dbReference type="ProteomicsDB" id="52101">
<molecule id="P08253-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="5336"/>
<dbReference type="ABCD" id="P08253">
<property type="antibodies" value="1 sequenced antibody"/>
</dbReference>
<dbReference type="Antibodypedia" id="773">
<property type="antibodies" value="1590 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="4313"/>
<dbReference type="Ensembl" id="ENST00000219070">
<molecule id="P08253-1"/>
<property type="protein sequence ID" value="ENSP00000219070"/>
<property type="gene ID" value="ENSG00000087245"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000437642">
<molecule id="P08253-3"/>
<property type="protein sequence ID" value="ENSP00000394237"/>
<property type="gene ID" value="ENSG00000087245"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000543485">
<molecule id="P08253-2"/>
<property type="protein sequence ID" value="ENSP00000444143"/>
<property type="gene ID" value="ENSG00000087245"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000570308">
<molecule id="P08253-2"/>
<property type="protein sequence ID" value="ENSP00000461421"/>
<property type="gene ID" value="ENSG00000087245"/>
</dbReference>
<dbReference type="GeneID" id="4313"/>
<dbReference type="KEGG" id="hsa:4313"/>
<dbReference type="UCSC" id="uc002ehz.5">
<molecule id="P08253-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="4313"/>
<dbReference type="DisGeNET" id="4313"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000087245.12"/>
<dbReference type="GeneCards" id="MMP2"/>
<dbReference type="GeneReviews" id="MMP2"/>
<dbReference type="HGNC" id="HGNC:7166">
<property type="gene designation" value="MMP2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000087245">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="MMP2"/>
<dbReference type="MIM" id="120360">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="259600">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P08253"/>
<dbReference type="OpenTargets" id="ENSG00000087245"/>
<dbReference type="Orphanet" id="371428">
<property type="disease" value="Multicentric osteolysis-nodulosis-arthropathy spectrum"/>
</dbReference>
<dbReference type="PharmGKB" id="PA30877"/>
<dbReference type="eggNOG" id="KOG1565">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000158511"/>
<dbReference type="HOGENOM" id="CLU_015489_6_2_1"/>
<dbReference type="InParanoid" id="P08253"/>
<dbReference type="KO" id="K01398"/>
<dbReference type="OMA" id="MWCATTK"/>
<dbReference type="OrthoDB" id="965164at2759"/>
<dbReference type="PhylomeDB" id="P08253"/>
<dbReference type="TreeFam" id="TF315428"/>
<dbReference type="BioCyc" id="MetaCyc:HS01565-MONOMER"/>
<dbReference type="BRENDA" id="3.4.24.24">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="PathwayCommons" id="P08253"/>
<dbReference type="Reactome" id="R-HSA-1442490">
<property type="pathway name" value="Collagen degradation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1474228">
<property type="pathway name" value="Degradation of the extracellular matrix"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1592389">
<property type="pathway name" value="Activation of Matrix Metalloproteinases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-381426">
<property type="pathway name" value="Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3928665">
<property type="pathway name" value="EPH-ephrin mediated repulsion of cells"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6785807">
<property type="pathway name" value="Interleukin-4 and Interleukin-13 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9009391">
<property type="pathway name" value="Extra-nuclear estrogen signaling"/>
</dbReference>
<dbReference type="SIGNOR" id="P08253"/>
<dbReference type="BioGRID-ORCS" id="4313">
<property type="hits" value="4 hits in 876 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="MMP2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P08253"/>
<dbReference type="GeneWiki" id="MMP2"/>
<dbReference type="GenomeRNAi" id="4313"/>
<dbReference type="Pharos" id="P08253">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:P08253"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 16"/>
</dbReference>
<dbReference type="RNAct" id="P08253">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000087245">
<property type="expression patterns" value="Expressed in stromal cell of endometrium and 221 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P08253">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P08253">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0062023">
<property type="term" value="C:collagen-containing extracellular matrix"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030017">
<property type="term" value="C:sarcomere"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004175">
<property type="term" value="F:endopeptidase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004222">
<property type="term" value="F:metalloendopeptidase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008237">
<property type="term" value="F:metallopeptidase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004252">
<property type="term" value="F:serine-type endopeptidase activity"/>
<property type="evidence" value="ECO:0000269"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0001525">
<property type="term" value="P:angiogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0001955">
<property type="term" value="P:blood vessel maturation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060346">
<property type="term" value="P:bone trabecula formation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0044267">
<property type="term" value="P:cellular protein metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0071230">
<property type="term" value="P:cellular response to amino acid stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034614">
<property type="term" value="P:cellular response to reactive oxygen species"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071492">
<property type="term" value="P:cellular response to UV-A"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030574">
<property type="term" value="P:collagen catabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0019221">
<property type="term" value="P:cytokine-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007566">
<property type="term" value="P:embryo implantation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035987">
<property type="term" value="P:endodermal cell differentiation"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048013">
<property type="term" value="P:ephrin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0022617">
<property type="term" value="P:extracellular matrix disassembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030198">
<property type="term" value="P:extracellular matrix organization"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0060325">
<property type="term" value="P:face morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001957">
<property type="term" value="P:intramembranous ossification"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1904707">
<property type="term" value="P:positive regulation of vascular associated smooth muscle cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006508">
<property type="term" value="P:proteolysis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1904645">
<property type="term" value="P:response to amyloid-beta"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001666">
<property type="term" value="P:response to hypoxia"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0048771">
<property type="term" value="P:tissue remodeling"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="CDD" id="cd00062">
<property type="entry name" value="FN2"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="CDD" id="cd00094">
<property type="entry name" value="HX"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd04278">
<property type="entry name" value="ZnMc_MMP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.101.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.10.10.10">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Gene3D" id="2.110.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.390.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00296"/>
<dbReference type="InterPro" id="IPR028708">
<property type="entry name" value="72kDa_collagenase"/>
</dbReference>
<dbReference type="InterPro" id="IPR000562">
<property type="entry name" value="FN_type2_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036943">
<property type="entry name" value="FN_type2_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000585">
<property type="entry name" value="Hemopexin-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036375">
<property type="entry name" value="Hemopexin-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR018487">
<property type="entry name" value="Hemopexin-like_repeat"/>
</dbReference>
<dbReference type="InterPro" id="IPR018486">
<property type="entry name" value="Hemopexin_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR013806">
<property type="entry name" value="Kringle-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR033739">
<property type="entry name" value="M10A_MMP"/>
</dbReference>
<dbReference type="InterPro" id="IPR024079">
<property type="entry name" value="MetalloPept_cat_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001818">
<property type="entry name" value="Pept_M10_metallopeptidase"/>
</dbReference>
<dbReference type="InterPro" id="IPR021190">
<property type="entry name" value="Pept_M10A"/>
</dbReference>
<dbReference type="InterPro" id="IPR021158">
<property type="entry name" value="Pept_M10A_Zn_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR006026">
<property type="entry name" value="Peptidase_Metallo"/>
</dbReference>
<dbReference type="InterPro" id="IPR002477">
<property type="entry name" value="Peptidoglycan-bd-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR036365">
<property type="entry name" value="PGBD-like_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR036366">
<property type="entry name" value="PGBDSf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10201:SF29">
<property type="entry name" value="PTHR10201:SF29"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00040">
<property type="entry name" value="fn2"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="Pfam" id="PF00045">
<property type="entry name" value="Hemopexin"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="Pfam" id="PF00413">
<property type="entry name" value="Peptidase_M10"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01471">
<property type="entry name" value="PG_binding_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF001191">
<property type="entry name" value="Peptidase_M10A_matrix"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00138">
<property type="entry name" value="MATRIXIN"/>
</dbReference>
<dbReference type="SMART" id="SM00059">
<property type="entry name" value="FN2"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00120">
<property type="entry name" value="HX"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="SMART" id="SM00235">
<property type="entry name" value="ZnMc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47090">
<property type="entry name" value="SSF47090"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50923">
<property type="entry name" value="SSF50923"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF57440">
<property type="entry name" value="SSF57440"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS00546">
<property type="entry name" value="CYSTEINE_SWITCH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00023">
<property type="entry name" value="FN2_1"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS51092">
<property type="entry name" value="FN2_2"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="PROSITE" id="PS00024">
<property type="entry name" value="HEMOPEXIN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51642">
<property type="entry name" value="HEMOPEXIN_2"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="PROSITE" id="PS00142">
<property type="entry name" value="ZINC_PROTEASE"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0037">Angiogenesis</keyword>
<keyword id="KW-0068">Autocatalytic cleavage</keyword>
<keyword id="KW-0106">Calcium</keyword>
<keyword id="KW-0177">Collagen degradation</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0272">Extracellular matrix</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0482">Metalloprotease</keyword>
<keyword id="KW-0496">Mitochondrion</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0645">Protease</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0865">Zymogen</keyword>
<feature type="signal peptide" evidence="35">
<location>
<begin position="1"/>
<end position="29"/>
</location>
</feature>
<feature type="propeptide" description="Activation peptide" id="PRO_0000028714">
<location>
<begin position="30"/>
<end position="109"/>
</location>
</feature>
<feature type="chain" description="72 kDa type IV collagenase" id="PRO_0000028715">
<location>
<begin position="110"/>
<end position="660"/>
</location>
</feature>
<feature type="chain" description="PEX" id="PRO_0000391626">
<location>
<begin position="445"/>
<end position="660"/>
</location>
</feature>
<feature type="domain" description="Fibronectin type-II 1" evidence="14">
<location>
<begin position="228"/>
<end position="276"/>
</location>
</feature>
<feature type="domain" description="Fibronectin type-II 2" evidence="14">
<location>
<begin position="286"/>
<end position="334"/>
</location>
</feature>
<feature type="domain" description="Fibronectin type-II 3" evidence="14">
<location>
<begin position="344"/>
<end position="392"/>
</location>
</feature>
<feature type="repeat" description="Hemopexin 1">
<location>
<begin position="472"/>
<end position="516"/>
</location>
</feature>
<feature type="repeat" description="Hemopexin 2">
<location>
<begin position="517"/>
<end position="563"/>
</location>
</feature>
<feature type="repeat" description="Hemopexin 3">
<location>
<begin position="565"/>
<end position="613"/>
</location>
</feature>
<feature type="repeat" description="Hemopexin 4">
<location>
<begin position="614"/>
<end position="660"/>
</location>
</feature>
<feature type="region of interest" description="Collagenase-like 1">
<location>
<begin position="110"/>
<end position="221"/>
</location>
</feature>
<feature type="region of interest" description="Collagen-binding">
<location>
<begin position="222"/>
<end position="396"/>
</location>
</feature>
<feature type="region of interest" description="Collagenase-like 2">
<location>
<begin position="397"/>
<end position="465"/>
</location>
</feature>
<feature type="region of interest" description="Required for inhibitor TIMP2 binding" evidence="29">
<location>
<begin position="414"/>
<end position="660"/>
</location>
</feature>
<feature type="short sequence motif" description="Cysteine switch" evidence="12">
<location>
<begin position="100"/>
<end position="107"/>
</location>
</feature>
<feature type="active site" evidence="15 44">
<location>
<position position="404"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1; in inhibited form" evidence="1 3 5 16 24">
<location>
<position position="102"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 1" evidence="9 11 34">
<location>
<position position="134"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 2; via carbonyl oxygen" evidence="3 11 34">
<location>
<position position="168"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="1 3 5 9 11 16 24 34">
<location>
<position position="178"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="1 3 5 9 11 16 24 34">
<location>
<position position="180"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 3" evidence="11 34">
<location>
<position position="185"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 3; via carbonyl oxygen" evidence="11 34">
<location>
<position position="186"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="1 3 5 9 11 16 24 34">
<location>
<position position="193"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 2; via carbonyl oxygen" evidence="3 11 34">
<location>
<position position="200"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 2; via carbonyl oxygen" evidence="11 34">
<location>
<position position="202"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 2" evidence="11 34">
<location>
<position position="204"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="1 3 5 9 11 16 24 34">
<location>
<position position="206"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 3" evidence="11 34">
<location>
<position position="208"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 1" evidence="9 11 34">
<location>
<position position="209"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 1; via carbonyl oxygen" evidence="9 11 34">
<location>
<position position="211"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 3" evidence="11 34">
<location>
<position position="211"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1; catalytic" evidence="1 3 5 11 16 24 34">
<location>
<position position="403"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1; catalytic" evidence="1 3 5 11 16 24 34">
<location>
<position position="407"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1; catalytic" evidence="1 3 5 11 16 24 34">
<location>
<position position="413"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 4; via carbonyl oxygen" evidence="1 10 16 36">
<location>
<position position="476"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 4; via carbonyl oxygen" evidence="1 10 16 36">
<location>
<position position="521"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 4; via carbonyl oxygen" evidence="1 10 16 36">
<location>
<position position="569"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Calcium 4; via carbonyl oxygen" evidence="1 10 16 36">
<location>
<position position="618"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="13">
<location>
<position position="573"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="13">
<location>
<position position="642"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3 5 8 14 23 24">
<location>
<begin position="233"/>
<end position="259"/>
</location>
</feature>
<feature type="disulfide bond" evidence="3 5 8 14 17 23">
<location>
<begin position="247"/>
<end position="274"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 5 14 16 17 24">
<location>
<begin position="291"/>
<end position="317"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 5 14 16 17 24">
<location>
<begin position="305"/>
<end position="332"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 5 14 16 17 24">
<location>
<begin position="349"/>
<end position="375"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 5 14 16 17 24">
<location>
<begin position="363"/>
<end position="390"/>
</location>
</feature>
<feature type="disulfide bond" evidence="1 2 3 5 14 16 17 24">
<location>
<begin position="469"/>
<end position="660"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_044631" evidence="39">
<location>
<begin position="1"/>
<end position="76"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_045704" evidence="39">
<original>MEALMARGALTGPLRALCLLGCLLSHAAAAPSPIIKFPGDVAPKTDKELAV</original>
<variation>M</variation>
<location>
<begin position="1"/>
<end position="51"/>
</location>
</feature>
<feature type="sequence variant" description="In MONA; dbSNP:rs121912953." id="VAR_032423" evidence="20">
<original>R</original>
<variation>H</variation>
<location>
<position position="101"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_032424" evidence="20">
<original>D</original>
<variation>Y</variation>
<location>
<position position="210"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal cancer sample; somatic mutation; dbSNP:rs759302357." id="VAR_036136" evidence="30">
<original>A</original>
<variation>T</variation>
<location>
<position position="228"/>
</location>
</feature>
<feature type="sequence variant" description="In MONA." id="VAR_054996" evidence="28">
<location>
<position position="400"/>
</location>
</feature>
<feature type="sequence variant" description="In MONA; dbSNP:rs121912955." id="VAR_032425" evidence="27">
<original>E</original>
<variation>K</variation>
<location>
<position position="404"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17859943." id="VAR_020616" evidence="38">
<original>A</original>
<variation>V</variation>
<location>
<position position="447"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal cancer sample; somatic mutation; dbSNP:rs764961297." id="VAR_036137" evidence="30">
<original>T</original>
<variation>M</variation>
<location>
<position position="498"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs16955280." id="VAR_020617" evidence="38">
<original>V</original>
<variation>L</variation>
<location>
<position position="621"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal cancer sample; somatic mutation." id="VAR_036138" evidence="30">
<original>S</original>
<variation>I</variation>
<location>
<position position="644"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AK310314." ref="3" evidence="43">
<original>F</original>
<variation>S</variation>
<location>
<position position="235"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAG35588." ref="3" evidence="43">
<original>S</original>
<variation>G</variation>
<location>
<position position="546"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAG35588." ref="3" evidence="43">
<original>D</original>
<variation>G</variation>
<location>
<position position="618"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="46"/>
<end position="56"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="62"/>
<end position="64"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="67"/>
<end position="80"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="86"/>
<end position="88"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="91"/>
<end position="97"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="111"/>
<end position="113"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="120"/>
<end position="128"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="133"/>
<end position="135"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="137"/>
<end position="152"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="154"/>
<end position="156"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="158"/>
<end position="161"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="163"/>
<end position="165"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="168"/>
<end position="174"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="179"/>
<end position="181"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="186"/>
<end position="189"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="192"/>
<end position="195"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="197"/>
<end position="199"/>
</location>
</feature>
<feature type="turn" evidence="11">
<location>
<begin position="200"/>
<end position="203"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="205"/>
<end position="208"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="209"/>
<end position="211"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="213"/>
<end position="216"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="226"/>
<end position="228"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="235"/>
<end position="239"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="242"/>
<end position="246"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="258"/>
<end position="264"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="265"/>
<end position="267"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="271"/>
<end position="273"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="277"/>
<end position="279"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="284"/>
<end position="288"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="293"/>
<end position="297"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="300"/>
<end position="304"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="316"/>
<end position="321"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="323"/>
<end position="325"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="329"/>
<end position="331"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="338"/>
<end position="341"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="342"/>
<end position="346"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="351"/>
<end position="355"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="358"/>
<end position="362"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="369"/>
<end position="371"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="374"/>
<end position="379"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="381"/>
<end position="384"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="387"/>
<end position="389"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="394"/>
<end position="396"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="397"/>
<end position="408"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="422"/>
<end position="424"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="435"/>
<end position="445"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="468"/>
<end position="470"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="476"/>
<end position="481"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="484"/>
<end position="489"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="492"/>
<end position="498"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="504"/>
<end position="508"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="509"/>
<end position="511"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="514"/>
<end position="516"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="521"/>
<end position="526"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="527"/>
<end position="530"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="531"/>
<end position="536"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="539"/>
<end position="544"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="553"/>
<end position="555"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="556"/>
<end position="559"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="563"/>
<end position="566"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="569"/>
<end position="573"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="575"/>
<end position="577"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="580"/>
<end position="584"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="587"/>
<end position="592"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="593"/>
<end position="596"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="606"/>
<end position="609"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="610"/>
<end position="612"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="618"/>
<end position="622"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="624"/>
<end position="626"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="628"/>
<end position="633"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="636"/>
<end position="641"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="644"/>
<end position="652"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="653"/>
<end position="656"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1CK7"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1CXW"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1EAK"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1GEN"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1GXD"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1HOV"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1J7M"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1KS0"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1QIB"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1RTG"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3AYU"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000250"/>
<evidence key="13" type="ECO:0000255"/>
<evidence key="14" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00479"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10095"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10356396"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10545322"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11179305"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11320090"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11431697"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11710594"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11751392"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11928808"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12032297"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12147339"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12879005"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15691365"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16542393"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1655733"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17435175"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18971601"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19493954"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21813640"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2834383"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8549817"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9119036"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source ref="4"/>
</evidence>
<evidence key="39" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1655733"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2162831"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="2834383"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000305"/>
<evidence key="44" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="10356396"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="11179305"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="11431697"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="12147339"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="2834383"/>
</source>
</evidence>
<sequence length="660" mass="73882" checksum="BC7147DC8B49F289" modified="1991-02-01" version="2" precursor="true">MEALMARGALTGPLRALCLLGCLLSHAAAAPSPIIKFPGDVAPKTDKELAVQYLNTFYGCPKESCNLFVLKDTLKKMQKFFGLPQTGDLDQNTIETMRKPRCGNPDVANYNFFPRKPKWDKNQITYRIIGYTPDLDPETVDDAFARAFQVWSDVTPLRFSRIHDGEADIMINFGRWEHGDGYPFDGKDGLLAHAFAPGTGVGGDSHFDDDELWTLGEGQVVRVKYGNADGEYCKFPFLFNGKEYNSCTDTGRSDGFLWCSTTYNFEKDGKYGFCPHEALFTMGGNAEGQPCKFPFRFQGTSYDSCTTEGRTDGYRWCGTTEDYDRDKKYGFCPETAMSTVGGNSEGAPCVFPFTFLGNKYESCTSAGRSDGKMWCATTANYDDDRKWGFCPDQGYSLFLVAAHEFGHAMGLEHSQDPGALMAPIYTYTKNFRLSQDDIKGIQELYGASPDIDLGTGPTPTLGPVTPEICKQDIVFDGIAQIRGEIFFFKDRFIWRTVTPRDKPMGPLLVATFWPELPEKIDAVYEAPQEEKAVFFAGNEYWIYSASTLERGYPKPLTSLGLPPDVQRVDAAFNWSKNKKTYIFAGDKFWRYNEVKKKMDPGFPKLIADAWNAIPDNLDAVVDLQGGGHSYFFKGAYYLKLENQSLKSVKFGSIKSDWLGC</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

